Glutamine addiction commonly occurs in tumors, especially when it is driven by c-myc mutations and mTOR activation, which increase HCC cells’ metabolic dependence on exogenous glutamine and elevated glutamine catabolism. Here, MTOR is linked to hepatocellular carcinoma.